Treace Medical Concepts, Inc.
NMS: TMCILive Quote
📈 ZcoreAI Score
Our AI model analyzes Treace Medical Concepts, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get TMCI Z-Score →About Treace Medical Concepts, Inc.
Healthcare
Medical Devices
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
📊 Fundamental Analysis
Treace Medical Concepts, Inc. demonstrates a profit margin of -27.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported -9.0% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -58.9%, which indicates that capital utilization is currently under pressure.
At a current price of $1.81, TMCI currently trades near the bottom of its 52-week range (10%), indicating potential value or weakness (Range: $1.17 - $7.78).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$117.26M
Trailing P/E
--
Forward P/E
-2.01
Beta (5Y)
0.88
52W High
$7.78
52W Low
$1.17
Avg Volume
868K
Day High
Day Low